{"nctId":"NCT00091507","briefTitle":"IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.","startDateStruct":{"date":"2006-11"},"conditions":["Angina, Unstable","Cardiovascular Diseases","Heart Diseases","Coronary Disease","Myocardial Infarction","Heart Failure, Congestive"],"count":911,"armGroups":[{"label":"1 -- GIK","type":"EXPERIMENTAL","interventionNames":["Drug: GIK"]},{"label":"2 -- Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"GIK","otherNames":["Glucose-Insulin Potassium"]},{"name":"Placebo","otherNames":["Dextrose 5%"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Symptoms of threatened or established AMI including but not limited to:\n\n  1. Chest pain, discomfort, or tightness\n  2. Arm or shoulder pain\n  3. Jaw pain\n  4. Epigastric discomfort\n  5. Shortness of breath\n* 12-lead electrocardiogram (ECG) with two or more contiguous leads with ST elevation greater than 1 mm, ST depression greater than 0.5 mm, T wave inversion or other T wave abnormalities (hyperacute T waves), or left bundle branch block (not known to be old). Identification aided by the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI)and thrombolytic predictive instrument (TPI) decision support software (ACI-TIPI \\>= 75% and TPI detection of suspected STEMI).\n\nExclusion Criteria:\n\n* End-stage kidney failure requiring dialysis\n* Rales present more than halfway up the back\n* Unable to comply with the requirements of the study\n* Incarcerated\n* Known to be pregnant","healthyVolunteers":false,"sex":"ALL","minimumAge":"30 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Progression of Acute Coronary Syndrome to Myocardial Infarction","description":"Outcome for all participants during the first 24 hours of hospitalization; evidence of myocardial infarction is determined by ECG and biomarker results.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"200","spread":null},{"groupId":"OG001","value":"242","spread":null}]}]}]},{"type":"SECONDARY","title":"Cardiac Arrest","description":"Outcome for all participants who had a cardiac arrest from initial contact in the prehospital setting through their subsequent hospitalization.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null},{"groupId":"OG001","value":"29","spread":null}]}]}]},{"type":"SECONDARY","title":"Heart Failure or Death","description":"Outcome for all participants (composite of re-hospitalization for heart failure or death within 30 days)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23","spread":null},{"groupId":"OG001","value":"35","spread":null}]}]}]},{"type":"SECONDARY","title":"Mortality","description":"Outcome for all participants (mortality at 30 days).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null},{"groupId":"OG001","value":"28","spread":null}]}]}]},{"type":"SECONDARY","title":"Cardiac Arrest or Acute Mortality","description":"Outcome for all participants (composite of cardiac arrest or acute mortality)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null},{"groupId":"OG001","value":"40","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":28,"n":411},"commonTop":["Hyperglycaemia","Injection site reaction","Ventricular extrasystoles","Hypotension","Ventricular tachycardia"]}}}